New Zealand King Salmon Investments (NZK)•HY26•Released 25 September 2025NZK swings to $20.8m loss as FY26 EBITDA guidance collapses to $1–7mA biological-asset write-down and lower harvest volumes drive a statutory loss, yet operating cash and net cash both improved versus HY25.Published 23 April 2026Read briefing→
New Zealand King Salmon Investments (NZK)•FY25•Released 27 March 2025Pro-forma EBITDA up 21% but NPAT halved as FY24's PBT boost did not repeatOperating cash flow nearly tripled to $38.5m and the net cash pile almost doubled, yet statutory profit fell 53% and FY26 harvests are flagged as...Published 23 April 2026Read briefing→
New Zealand King Salmon Investments (NZK)•HY25•Released 24 September 2024Statutory NPAT down 43.5% and FY25 EBITDA ceiling cut despite 11% revenue liftPro-forma EBITDA rose to NZ$13.5m while statutory EBITDA fell to NZ$12.5m, with no disclosed bridge between the two measures.Published 23 April 2026Read briefing→
New Zealand King Salmon Investments (NZK)•FY24•Released 27 March 2024NZK FY24 EBITDA reached $24.5m but 75% landed in H1The turnaround is real on a full-year basis, yet implied 2H EBITDA of just $6.0m sets a softer base against FY25 guidance of $26m-$32m.Published 21 April 2026Read briefing→
New Zealand King Salmon Investments (NZK)•HY24•Released 21 September 2023EBITDA swings NZ$36.4m as post-mortality recovery drives guidance upgradeRevenue up 14.4% and gross margin up ~40 points, but the comparison laps a mortality-impacted half and guidance remains on a pro-forma basis.Published 21 April 2026Read briefing→